Patents by Inventor Piotr J. Masiakowski

Piotr J. Masiakowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel orphan cytokine receptor polypeptides
    Publication number: 20030228653
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
    Type: Application
    Filed: December 14, 2000
    Publication date: December 11, 2003
    Inventor: Piotr J. Masiakowski
  • Novel orphan receptors
    Publication number: 20020164785
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
    Type: Application
    Filed: February 12, 2002
    Publication date: November 7, 2002
    Inventor: Piotr J. Masiakowski
  • Novel orphan receptors
    Publication number: 20020160451
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated HUMAN OCR10. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the HUMAN OCR10 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between HUMAN OCR10 and agents that initiate signal transduction through binding to HUMAN OCR10.
    Type: Application
    Filed: August 29, 2001
    Publication date: October 31, 2002
    Inventors: Piotr J. Masiakowski, Jodi Morris, David M. Valenzuela
  • Novel orphan receptors
    Publication number: 20020052020
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
    Type: Application
    Filed: November 17, 1999
    Publication date: May 2, 2002
    Inventor: Piotr J. Masiakowski
  • Nucleic acids encoding novel orphan cytokine receptors
    Patent number: 6207413
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
    Type: Grant
    Filed: July 22, 1998
    Date of Patent: March 27, 2001
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventor: Piotr J. Masiakowski
  • Nucleic acids encoding novel orphan cytokine receptors
    Patent number: 6060276
    Abstract: The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: May 9, 2000
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventor: Piotr J. Masiakowski